PATENT CLAIM ANALYSIS

Application Number: 15751778
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["424", "001890"]

Abstract:
The present application provides compounds useful in methods of treating neurological disorders such as Alzheimer's disease, and cancer such as prostate cancer. Also provided herein are radiolabeled compounds useful for imaging techniques, and techniques for diagnosis and monitoring of treatment of neurological disorders and cancer. An exemplary radiolabeled compound provided herein is useful as a radiotracer for positron emission tomography or single-photon emission computed tomography. Methods for preparing radiolabeled compounds and methods for preparing unlabeled compounds are also provided.

Claim (Index 208):
A method of diagnosing a disorder selected from a neurological disorder and a cancer in a subject, the method comprising:\n i) administering to the subject a compound of  claim 205 , or a pharmaceutically acceptable salt thereof; ii) waiting a time sufficient to allow the compound to accumulate at a tissue or cell site associated with the disorder; and iii) imaging the cell or tissue with an imaging technique.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 88.0
- Lexical Diversity: 1.7551
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15543826', '15326890', '12956146', '15884833', '13515638']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7086399302359209
- 35 USC 102 Novelty (BERT): 0.5194791083162692
- Combined Prediction Score: 0.6897238480439558
- Mean Citation Score: 279.745556
- Max Citation Score: 289.80746
- Similarity Product: 167.4935653210187

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test